Global Topical Hemostat Market Size to worth USD 13.18 Billion by 2033
According to a research report published by Spherical Insights & Consulting, The Global Topical Hemostat Market Size is Expected to Grow from USD 5.39 Billion in 2023 to USD 13.18 Billion by 2033, at a CAGR of 9.35% during the forecast period 2023-2033.
Browse key industry insights spread across 210 pages with 110 Market data tables and figures & charts from the report on the Global Topical Hemostat Market Size, Share, and COVID-19 Impact Analysis, By Type (Fibrin, Thrombin, Cellulose, Collagen, Gelatin, Adhesives, and Others), By Application (General Surgery, Neurosurgery, Vascular Surgery, Cardiovascular Surgery, and Others), By End-use (Hospitals, Ambulatory Surgical Centers, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033
Products that facilitate hemostasis at the application site and reduce bleeding during surgical operations are included in the topical hemostat market. These substances are essential for lowering surgical problems, improving the visibility of the operating field, and minimizing blood loss. Topical hemostats are utilized in a variety of surgical specialities, such as orthopedic, neurological, and cardiovascular surgery, and are administered directly to the bleeding site. The desire for better patient outcomes, fewer surgical complications, and quicker wound healing is driving the demand. Increases in minimally invasive procedures and expanding healthcare infrastructure, especially in emerging nations, are further factors driving market expansion. The growing number of surgical procedures performed worldwide, the prevalence of chronic conditions that necessitate surgery, improvements in hemostatic product technology, and increased awareness of effective blood loss management are the main drivers driving the expansion of the topical hemostat market. However, the high price of sophisticated hemostatic medicines and strict regulatory procedures that could delay quick product approvals restrict the growth of the topical hemostat market.
The thrombin segment held the highest share in 2023 and is anticipated to grow at a significant CAGR during the projected timeframe.
Based on the type, the topical hemostat market is classified into fibrin, thrombin, cellulose, collagen, gelatin, adhesives, and others. Among these, the thrombin segment held the highest share in 2023 and is anticipated to grow at a significant CAGR during the projected timeframe. The thrombin is used extensively in surgical procedures and is highly effective in promoting rapid blood clotting. Products based on thrombin are preferred due to they are simple to use, have few side effects, and can improve hemostasis when paired with other substances like fibrin.
The general surgery application segment held the highest share in 2023 and is anticipated to grow at a significant CAGR during the projected timeframe.
Based on the application, the topical hemostat market is divided into general surgery, neurosurgery, vascular surgery, cardiovascular surgery, and others. Among these, the general surgery segment held the highest share in 2023 and is anticipated to grow at a significant CAGR during the projected timeframe. General surgery is driven by the large number of procedures that need to be done with good bleeding control. Advanced hemostatic solutions are often required for these surgeries, which include soft tissue, thoracic, and abdominal procedures, to reduce blood loss and improve patient outcomes.
The hospitals segment held the highest share in 2023 and is anticipated to grow at a significant CAGR during the projected timeframe.
Based on the end use, the topical hemostat market is divided into hospitals, ambulatory surgical centers, and others. Among these, the hospitals segment held the highest share in 2023 and is anticipated to grow at a significant CAGR during the projected timeframe. The volume of procedures conducted in hospitals, such as general, orthopedic, and neuro surgeries, which necessitate efficient hemostatic treatments to control bleeding, is the main factor driving the hospitals.
North America is estimated to hold the highest share of the topical hemostat market over the forecast period.
North America is estimated to hold the highest share of the topical hemostat market over the forecast period. In the United States, 40–50 million procedures are performed there each year to treat disorders like trauma, cancer, and cardiovascular problems. The demand for surgical instruments is driven by an increase in procedures. Innovation is encouraged in the topical hemostat industry by the existence of premier businesses and research facilities. Additionally, investments in healthcare technology and regulatory assistance fuel industry expansion.
Asia Pacific is expected to grow at a rapid pace in the global topical hemostat market during the forecast period. The market for topical hemostats is expanding quickly in Asia Pacific as a result of an increase in chronic illnesses such as diabetes, cancer, and cardiovascular disorders, especially in China, India, and Japan. Patient outcomes are also being improved by the use of minimally invasive procedures and advancements in surgical equipment, such as topical hemostats.
Company Profiling
Major key players in the topical hemostat market include BD, Integra LifeSciences, Medicom, Pfizer Inc., Hemostasis, LLC, Baxter, Johnson & Johnson, Medline Industries, HemCon, Medical Technologies Inc., HemoSonics, Teleflex Incorporated. and Others
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In July 2024, Premier, Inc. and Teleflex Incorporated announced two group purchasing agreements that give Premier members access to exclusive prices on Teleflex's hemostatic products, such as QuikClot Hemostatic Dressings and Devices, which stop bleeding more quickly than conventional gauze or laparotomy pads.
- In April 2024, DonorSeal, a 100% natural cellulose matrix derived from plants, was launched by LifeScience PLUS to improve hemostasis and accelerate wound healing at donor sites. It gels when it comes into touch with blood, forming a wet environment that promotes tissue regeneration. All age groups can safely use DonorSeal is biodegradable and absorbable.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the topical hemostat market based on the below-mentioned segments:
Global Topical Hemostat Market, By Type
- Fibrin
- Thrombin
- Cellulose
- Collagen
- Gelatin
- Adhesives
- Others
Global Topical Hemostat Market, By Application
- General Surgery
- Neurosurgery
- Vascular Surgery
- Cardiovascular Surgery
- Others
Global Topical Hemostat Market, By End Use
- Hospitals
- Ambulatory Surgical Centers
- Others
Global Topical Hemostat Market, By Regional Analysis
- North America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa